Heart failure and breast cancer: Emerging controversies regarding some cardioprotective strategies

Journal of Cardiac Failure

Volumn 20, Issue 6, 2014, Pages 456-457

  Patanè, Salvatore ^a  

^a Cardiologia Ospedale San Vincenzo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; SOTALOL; TRASTUZUMAB; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVOR; CANCER THERAPY; CARDIOTOXICITY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; CHEMICALLY INDUCED; DRUG THERAPY; EARLY INTERVENTION; FEMALE; HEART LEFT VENTRICLE FUNCTION; MALE; NEOPLASMS; PROCEDURES;

ANTINEOPLASTIC AGENTS; CARDIOVASCULAR AGENTS; EARLY MEDICAL INTERVENTION; FEMALE; HUMANS; MALE; NEOPLASMS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84901216474     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.04.014     Document Type: Letter

References (18)

1. A. Thakur, and R.M. Witteles Cancer therapy-induced left ventricular dysfunction: interventions and prognosis J Card Fail 20 2014 155 158
2. K. Kalam, and T.H. Marwick Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis Eur J Cancer 49 2013 2900 2909
3. R.M. Steingart, N. Yadav, C. Manrique, J.R. Carver, and J. Liu Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management Semin Oncol 40 2013 690 708
4. D.J. Lenihan Reversibility of effectively treated chemotherapy related heart failure: raising our awareness and a call to action for cardiology J Card Fail 20 2014 159 160
5. M. Ammon, N. Arenja, G. Leibundgut, R.R. Buechel, G.M. Kuster, and B.A. Kaufmann et al. Cardiovascular management of cancer patients with chemotherapy-associated left ventricular systolic dysfunction in real-world clinical practice J Card Fail 19 2013 629 634
6. B.A. McLean, P. Zhabyeyev, E. Pituskin, I. Paterson, M.J. Haykowsky, and G.Y. Oudit PI3K inhibitors as novel cancer therapies: implications for cardiovascular medicine J Card Fail 19 2013 268 282
7. C.A. Geisberg, W.M. Abdallah, M. da Silva, C. Silverstein, H.M. Smith, and V. Abramson et al. Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort J Card Fail 19 2013 10 15
8. L. Tarantini, G. Cioffi, S. Gori, F. Tuccia, L. Boccardi, D. Bovelli Italian Cardio-Oncologic Network Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer J Card Fail 18 2012 113 119
9. M. Monami, L. Filippi, A. Ungar, F. Sgrilli, A. Antenore, and I. Dicembrini et al. Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials Curr Med Res Opin 29 2013 369 378
10. D.M. Boudreau, O. Yu, J. Chubak, H.S. Wirtz, E.J. Bowles, and M. Fujii et al. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer Breast Cancer Res Treat 2014 Feb 21 [Epub ahead of print]
11. S. Seicean, A. Seicean, N. Alan, J.C. Plana, G.T. Budd, and T.H. Marwick Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure Circ Heart Fail 6 2013 420 426
12. P.A. Ganz, L.A. Habel, E.K. Weltzien, B.J. Caan, and S.W. Cole Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort Breast Cancer Res Treat 129 2011 549 556
13. G.V. Sørensen, P.A. Ganz, S.W. Cole, L.A. Pedersen, H.T. Sørensen, and D.P. Cronin-Fenton et al. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study J Clin Oncol 31 2013 2265 2272
14. C.R. Cardwell, H.G. Coleman, L.J. Murray, F. Entschladen, and D.G. Powe Beta-blocker usage and breast cancer survival: a nested case-control study within a UK Clinical Practice Research Datalink cohort Int J Epidemiol 42 2013 1852 1861
15. C.R. Cardwell, Ú.C. Mc Menamin, B.M. Hicks, C. Hughes, M.M. Cantwell, and L.J. Murray Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts BMC Med 12 2014 28
16. S. Holmes, E.J. Griffith, G. Musto, and G.Y. Minuk Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study Cancer Epidemiol 37 2013 881 885
17. S. Oliva, G. Cioffi, S. Frattini, E.L. Simoncini, P. Faggiano, L. Boccardi Italian Cardio-oncological Network Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world? Oncologist 17 2012 917 924
18. M. Mazevet, M. Moulin, A. Llach-Martinez, C. Chargari, E. Deutsch, and A.M. Gomez et al. Complications of chemotherapy, a basic science update Presse Med 42 9 Pt 2 2013 e352 e361